Applications, hearings, determinations, etc.: Lifepoint, Inc.,

[Federal Register: December 2, 2003 (Volume 68, Number 231)]

[Notices]

[Page 67475-67476]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr02de03-98]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 25,

[[Page 67476]]

2003, Lifepoint, Inc., 10400 Trademark Street, Rancho Cucamonga, California 91730, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug

Schedule

Tetrahydrocannabinols (7370)............... I 3,4-Methylenedioxyamphetamine (7400)....... I 3,4-Methylenedioxy-N-ethylamphetamine

I (7404). 3,4-Methylenedioxymethamphetamine (7405)... I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II phencyclidine (7471)....................... II Benzoylecogonine (9180).................... II Morphine (9300)............................ II

The firm plans to produce small quantities of controlled substances for use in drug test kits.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objectives may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than February 2, 2004.

Dated: November 14, 2003. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 03-29961 Filed 12-1-03; 8:45 am]

BILLING CODE 4410-09-M